TR201901950A2 - Passi̇flora, gli̇si̇n, meti̇lfolat ve magnezyum treonat i̇çeren yeni̇ bi̇r kombi̇nasyon ve üreti̇m yöntemi̇ - Google Patents
Passi̇flora, gli̇si̇n, meti̇lfolat ve magnezyum treonat i̇çeren yeni̇ bi̇r kombi̇nasyon ve üreti̇m yöntemi̇ Download PDFInfo
- Publication number
- TR201901950A2 TR201901950A2 TR2019/01950A TR201901950A TR201901950A2 TR 201901950 A2 TR201901950 A2 TR 201901950A2 TR 2019/01950 A TR2019/01950 A TR 2019/01950A TR 201901950 A TR201901950 A TR 201901950A TR 201901950 A2 TR201901950 A2 TR 201901950A2
- Authority
- TR
- Turkey
- Prior art keywords
- passiflora
- magnesium
- production method
- treonate
- methylpholate
- Prior art date
Links
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 title abstract 4
- 241000218996 Passiflora Species 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 title 1
- 229910052749 magnesium Inorganic materials 0.000 title 1
- 239000011777 magnesium Substances 0.000 title 1
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 abstract 2
- 238000011282 treatment Methods 0.000 abstract 2
- 208000014094 Dystonic disease Diseases 0.000 abstract 1
- 239000004471 Glycine Substances 0.000 abstract 1
- 208000017657 Menopausal disease Diseases 0.000 abstract 1
- 208000019695 Migraine disease Diseases 0.000 abstract 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 abstract 1
- 206010029333 Neurosis Diseases 0.000 abstract 1
- 240000008440 Passiflora incarnata Species 0.000 abstract 1
- 235000011922 Passiflora incarnata Nutrition 0.000 abstract 1
- 206010036618 Premenstrual syndrome Diseases 0.000 abstract 1
- 208000027520 Somatoform disease Diseases 0.000 abstract 1
- 208000010118 dystonia Diseases 0.000 abstract 1
- 235000019152 folic acid Nutrition 0.000 abstract 1
- 239000011724 folic acid Substances 0.000 abstract 1
- 229960000304 folic acid Drugs 0.000 abstract 1
- 229940064128 l-methylfolate Drugs 0.000 abstract 1
- 235000007635 levomefolic acid Nutrition 0.000 abstract 1
- 239000011578 levomefolic acid Substances 0.000 abstract 1
- ZNOVTXRBGFNYRX-ABLWVSNPSA-N levomefolic acid Chemical compound C1NC=2NC(N)=NC(=O)C=2N(C)C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 ZNOVTXRBGFNYRX-ABLWVSNPSA-N 0.000 abstract 1
- 229940056905 magnesium l-threonate Drugs 0.000 abstract 1
- YVJOHOWNFPQSPP-BALCVSAKSA-L magnesium;(2r,3s)-2,3,4-trihydroxybutanoate Chemical compound [Mg+2].OC[C@H](O)[C@@H](O)C([O-])=O.OC[C@H](O)[C@@H](O)C([O-])=O YVJOHOWNFPQSPP-BALCVSAKSA-L 0.000 abstract 1
- 206010027599 migraine Diseases 0.000 abstract 1
- 208000015238 neurotic disease Diseases 0.000 abstract 1
- 239000000047 product Substances 0.000 abstract 1
- 239000013589 supplement Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/84—Valerianaceae (Valerian family), e.g. valerian
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medical Informatics (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Dispersion Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2019/01950A TR201901950A2 (tr) | 2019-02-08 | 2019-02-08 | Passi̇flora, gli̇si̇n, meti̇lfolat ve magnezyum treonat i̇çeren yeni̇ bi̇r kombi̇nasyon ve üreti̇m yöntemi̇ |
| PCT/TR2020/050081 WO2020162859A2 (fr) | 2019-02-08 | 2020-02-07 | Nouvelle combinaison contenant de la passiflore, de la glycine, du métylfolate et du thréonate de magnésium et son procédé de production |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2019/01950A TR201901950A2 (tr) | 2019-02-08 | 2019-02-08 | Passi̇flora, gli̇si̇n, meti̇lfolat ve magnezyum treonat i̇çeren yeni̇ bi̇r kombi̇nasyon ve üreti̇m yöntemi̇ |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR201901950A2 true TR201901950A2 (tr) | 2019-05-21 |
Family
ID=67954943
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2019/01950A TR201901950A2 (tr) | 2019-02-08 | 2019-02-08 | Passi̇flora, gli̇si̇n, meti̇lfolat ve magnezyum treonat i̇çeren yeni̇ bi̇r kombi̇nasyon ve üreti̇m yöntemi̇ |
Country Status (2)
| Country | Link |
|---|---|
| TR (1) | TR201901950A2 (fr) |
| WO (1) | WO2020162859A2 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE1028612B1 (fr) * | 2021-02-24 | 2022-04-06 | Vesale Pharmaceutica | Composition comprenant un extrait de safran, un peptide de caseine et un autre compose vegetal pour le traitement des troubles du sommeil, des troubles de l'humeur ou de l'anxiete |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030012824A1 (en) * | 2001-07-03 | 2003-01-16 | Ott Dana Beth | Orally administered anti-stress composition |
| AU2018292531A1 (en) * | 2017-06-27 | 2020-02-13 | Harmonix, Llc | Time release sleep aid system |
| ES2695503B2 (es) * | 2017-06-30 | 2020-05-08 | Pharmalink S L | Formulaciones encapsuladas |
-
2019
- 2019-02-08 TR TR2019/01950A patent/TR201901950A2/tr unknown
-
2020
- 2020-02-07 WO PCT/TR2020/050081 patent/WO2020162859A2/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2020162859A2 (fr) | 2020-08-13 |
| WO2020162859A3 (fr) | 2020-10-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201270225A1 (ru) | СОЕДИНЕНИЯ ДЛЯ УМЕНЬШЕНИЯ ПРОДУКЦИИ β-АМИЛОИДА | |
| CU20210029A7 (es) | Inhibidores de proteína tirosina fosfatasa shp2 útiles en el tratamiento de enfermedades | |
| EA202092899A1 (ru) | Гетероарильные соединения для лечения болезни гентингтона | |
| MA42606B1 (fr) | Sels d'un inhibiteur de lsd1 | |
| MX2012008626A (es) | Composiciones y metodos para potenciar la actividad de proteasoma. | |
| MA49760B1 (fr) | Mavacamten pour l'utilisation dans le traitement de la cardiomyopathie hypertrophique | |
| NO20063986L (no) | Anti-CD-38-humane antistoffer og anvendelse derav | |
| CL2008003004A1 (es) | Anticuerpo anti-esclerostina o su porción de enlace de antígeno; polinucleotido que lo codifica; vector; célula; proceso de producción; composición farmacéutica que lo comprende; método para identificar células y su uso para tratar trastornos óseos. | |
| EA201500802A1 (ru) | Способы профилактики и/или лечения кардиомиопатии и устранения симптомов кардиомиопатии, фармацевтическая композиция, векторы | |
| MA41778A (fr) | Dérivés de benzimidazole en tant qu'inhibiteurs de bromodomaine | |
| EA201890815A1 (ru) | Аминокислотные композиции с модифицированным высвобождением для перорального введения | |
| CN111712573A (zh) | 针对骨硬化蛋白的适体及其用途 | |
| EA201990418A1 (ru) | Производные оксадиазолопиридина для применения в качестве ингибиторов грелин-о-ацилтрасферазы (goat) | |
| TR201901950A2 (tr) | Passi̇flora, gli̇si̇n, meti̇lfolat ve magnezyum treonat i̇çeren yeni̇ bi̇r kombi̇nasyon ve üreti̇m yöntemi̇ | |
| EA202190888A1 (ru) | Пептид для применения в косметике | |
| UA107200C2 (uk) | ОДИНИЧНИЙ ВАРІАБЕЛЬНИЙ ДОМЕН ІМУНОГЛОБУЛІНУ ПРОТИ РЕЦЕПТОРА ТИПУ 1 TNFα | |
| MX2016007407A (es) | Peptidos resistentes a proteasa. | |
| EA202190481A1 (ru) | Трипептиды и лечение метаболических, сердечно-сосудистых и воспалительных заболеваний | |
| EA201391097A1 (ru) | СОЕДИНЕНИЯ ДЛЯ СНИЖЕНИЯ ВЫРАБОТКИ β-АМИЛОИДА | |
| MX382357B (es) | Métodos y composiciones para tratar infecciones fúngicas cutáneas. | |
| MX2024012306A (es) | Inhibidores lrrk2. | |
| BR112023003059A2 (pt) | Método de lavagem de roupas e uso de um método | |
| MX2018014966A (es) | Peptidos monolipidados resistentes a proteasas. | |
| FR3052056B1 (fr) | Composition comprenant un tensioactif anionique, un organosilane, une si-licone aminee et un polymere cationique associatif, et procede de traitement cosmetique | |
| SA522431585B1 (ar) | تركيبات تروفينتايد |